APA (7th ed.) Citation

RJM, R., W, A., AB, d. l. P., AL, H., A, J., DP, M., . . . J, P. (2025). Switching Patients With Congenital Adrenal Hyperplasia to Modified-Release Hydrocortisone Capsules: Relative Bioavailability and Disease Control. Clinical endocrinology, 103(3), 290. https://doi.org/10.1111/cen.15275

Chicago Style (17th ed.) Citation

RJM, Ross, et al. "Switching Patients With Congenital Adrenal Hyperplasia to Modified-Release Hydrocortisone Capsules: Relative Bioavailability and Disease Control." Clinical Endocrinology 103, no. 3 (2025): 290. https://doi.org/10.1111/cen.15275.

MLA (9th ed.) Citation

RJM, Ross, et al. "Switching Patients With Congenital Adrenal Hyperplasia to Modified-Release Hydrocortisone Capsules: Relative Bioavailability and Disease Control." Clinical Endocrinology, vol. 103, no. 3, 2025, p. 290, https://doi.org/10.1111/cen.15275.